VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $266,000 | +6.8% | 10,836 | -12.4% | 0.02% | +4.5% |
| Q2 2016 | $249,000 | -26.5% | 12,374 | -4.1% | 0.02% | +37.5% |
| Q1 2016 | $339,000 | -97.5% | 12,899 | -81.4% | 0.02% | -97.1% |
| Q1 2015 | $13,808,000 | -82.7% | 69,520 | -88.6% | 0.54% | -82.2% |
| Q3 2014 | $79,778,000 | -47.3% | 608,065 | -49.3% | 3.07% | -58.6% |
| Q2 2014 | $151,283,000 | – | 1,199,511 | – | 7.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |